11 β-HSD1 |
11 –beta-hydroxysteroid dehydrogenase type 1 |
11 β-HSD2 |
11 –beta-hydroxysteroid dehydrogenase type 2 |
ACE |
angiotensin converting enzyme |
ACEi |
angiotensin-converting enzyme inhibitor |
ADPKD |
autosomal dominant polycystic kidney disease |
AKI |
acute kidney injury |
AMPK |
AMP-activated protein kinase |
ApoE |
Apolipoprotein E |
AR |
androgen receptor |
ARB |
angiotensin receptor blockers |
BP |
blood pressure |
CHF |
congestive heart failure |
CKD |
chronic kidney disease |
CNS |
central nervous system |
CYP11B1 |
cytochrome P450 family 11 subfamily B member 1 |
CYP11B2 |
cytochrome P450 family 11 subfamily B member 2 |
DOCA |
deoxycorticosterone acetate |
EGFR |
epidermal growth factor receptor |
ENaC |
epithelial sodium channels |
EnC |
endothelial cell |
eGlx |
endothelial cell glycocalyx |
eNOS |
endothelial nitric oxide synthase |
ERK 1/2 |
extracellular signal-regulated kinase 1/2 |
ET-1 |
endothelin-1 |
FMD |
flow-mediated dilatation |
GPER (or GPR 30) |
G-protein associated oestrogen receptor |
HAC |
human adrenocortical carcinoma |
HEK |
human embryonic kidney |
HS |
heparan sulphate |
HUVEC |
human umbilical vein endothelial cells |
HYAL2 |
hyaluronidase 2 |
ICAM-1 |
intercellular adhesion molecule-1 |
MMP |
matrix metalloproteinase |
MR |
mineralocorticoid receptor |
NHE |
Na+-H+ exchanger |
NO |
nitric oxide |
ox-LDL |
oxidized low-density lipoprotein |
PR |
progesterone receptor |
RAAS |
renin angiotensin aldosterone system |
RCT |
randomized controlled trial |
SGK-1 |
serum and glucocorticoid- induced kinase 1 |
siRNA |
small interfering RNA |
St AR Protein |
steroidogenic acute regulatory protein |
VCAM-1 |
vascular cell adhesion molecule-1 |